173 related articles for article (PubMed ID: 29315963)
1. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.
Ng T; Dorajoo SR; Cheung YT; Lam YC; Yeo HL; Shwe M; Gan YX; Foo KM; Loh WK; Koo SL; Jain A; Lee GE; Dent R; Yap YS; Ng R; Chan A
Psychooncology; 2018 Apr; 27(4):1185-1192. PubMed ID: 29315963
[TBL] [Abstract][Full Text] [Related]
2. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
3. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
4. Cognitive Perception among Post-Chemotherapy, Non-Chemotherapy Breast Cancer Survivors and Non-Cancer.
Syarif H; Waluyo A; Afiyanti Y
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1775-1780. PubMed ID: 34181333
[TBL] [Abstract][Full Text] [Related]
5. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
[TBL] [Abstract][Full Text] [Related]
6. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
7. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
8. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
10. Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems.
Gutenkunst SL; Vardy JL; Dhillon HM; Bell ML
Support Care Cancer; 2021 Mar; 29(3):1377-1386. PubMed ID: 32666213
[TBL] [Abstract][Full Text] [Related]
11. Physical Activity Patterns and Relationships With Cognitive Function in Patients With Breast Cancer Before, During, and After Chemotherapy in a Prospective, Nationwide Study.
Salerno EA; Culakova E; Kleckner AS; Heckler CE; Lin PJ; Matthews CE; Conlin A; Weiselberg L; Mitchell J; Mustian KM; Janelsins MC
J Clin Oncol; 2021 Oct; 39(29):3283-3292. PubMed ID: 34406822
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.
Kobayashi LC; Cohen HJ; Zhai W; Zhou X; Small BJ; Luta G; Hurria A; Carroll J; Tometich D; McDonald BC; Graham D; Jim HSL; Jacobsen P; Root JC; Saykin AJ; Ahles TA; Mandelblatt J
Psychooncology; 2020 Jun; 29(6):1051-1059. PubMed ID: 32154959
[TBL] [Abstract][Full Text] [Related]
13. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC
J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173
[TBL] [Abstract][Full Text] [Related]
14. NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer.
Rick O; Reuß-Borst M; Dauelsberg T; Hass HG; König V; Caspari R; Götz-Keil G; Pfitzner J; Kerschgens C; Fliessbach K; Hoppe C
Psychooncology; 2018 Aug; 27(8):2016-2022. PubMed ID: 29771474
[TBL] [Abstract][Full Text] [Related]
15. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
Gokal K; Munir F; Ahmed S; Kancherla K; Wallis D
PLoS One; 2018; 13(11):e0206874. PubMed ID: 30485297
[TBL] [Abstract][Full Text] [Related]
16. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
[TBL] [Abstract][Full Text] [Related]
17. Subjective cognition and memory lapses in the daily lives of breast cancer survivors: Examining associations with objective cognitive performance, fatigue, and depressed mood.
Veal BM; Scott SB; Jim HSL; Small BJ
Psychooncology; 2023 Aug; 32(8):1298-1305. PubMed ID: 37381150
[TBL] [Abstract][Full Text] [Related]
18. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
[TBL] [Abstract][Full Text] [Related]
19. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study.
Zeng Y; Cheng ASK; Song T; Sheng X; Zhang Y; Liu X; Chan CCH
BMC Cancer; 2017 Nov; 17(1):796. PubMed ID: 29179739
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
